# Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

> **NCT01002118** · NA · TERMINATED · sponsor: **University of Iowa** · enrollment: 1 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Omega-3 Acid Ethyl Esters
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01002118
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01-25
- **Primary completion:** 2011-02-23
- **Final completion:** 2011-02-23
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Unable to recruit eligible subjects; no data analyzed
- **Last updated:** 2017-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002118, "Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01002118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*